Govt. Programs
Home » Govt. Programs
Navigene proudly partners with various government programs across all levels, offering lowcost but highly effective diagnostic as wells as logistic solutions for scalable massscreening initiatives
Sickle Cell and Thalassemia Screening for 3 Tribal Districts of Bastar Region, Chattisgarh Under DMF Scheme. (Completed in 2023)
Sickle Cell and Thalassemia Screening for 3 Tribal Districts of Bastar Region, Chattisgarh Under DMF Scheme. (Completed in 2023)
- Executed the screening in the remotest tribal areas of Bijapur, Narayanpur, and Sukma districts of Bastar, Chattisgarh
- Processed 25 thousand DBS samples and delivered reports within 3 months
- Excellent feedback from Asha Workers and Health department in terms of ease of sample collection and the smoothness of the process
- Accurate diagnosis of the tribal population with overall POSITIVITY RATE of 15% for all hemoglobinopathies.
Comprehensive screening for Sickle Cell, Thalassemia and other Hemoglobinopathies in 21 Districts for NHM-Odisha under National Sickle Cell Anaemia Elimination Mission (Started in 2024 and Ongoing)
Comprehensive screening for Sickle Cell, Thalassemia and other hemoglobinopathies Screening in 21 Districts for NHM-Odisha under National Sickle cell Elimination Mission (Started in 2024 and Ongoing)
- One of the largest and most comprehensive Hemoglobinopathy (Sickle Cell/Thalassemia and other Hemoglobinopathies) population screening programs in India using DBS-HPLC methodology
- Partnered with Mediera Life Sciences, Cuttack and NHM Odisha, to execute this project on a scale and efficiently in 21 districts
- Set up the Asia’s largest HPLC lab in Cuttack with a processing capacity of 3 lakh samples/ month.
- End to end services from sample collection from PHCs, CHCs to uploading result data in NIC portal.
- Incorporated many critical process improvements in sample collection, data integrity, IT interventions and seamless reporting protocols to make the program robust and credible
- Developed a proprietary methodology to process samples at 3X rates as compared to a standard HPLC, thereby supporting mass scale screening programs.
- Used Navisys AI, for accurate processing and HPLC data handing at large scale
- Processed, reported and uploaded the data to the NIC portal for more than 12 Lakh (as of July 25) samples for both Sickle Cell, Beta Thalassemia and other variant hemoglobinopathies
- Overall Sickle cell positive rate of approximately 3 % for Sickle cell Disease and 10% for Sickle cell trait was found